Skip to main content
main-content

01.12.2012 | Correspondence | Ausgabe 1/2012 Open Access

BMC Medical Informatics and Decision Making 1/2012

Evaluating genomic tests from bench to bedside: a practical framework

Zeitschrift:
BMC Medical Informatics and Decision Making > Ausgabe 1/2012
Autoren:
Jennifer S Lin, Matthew Thompson, Katrina AB Goddard, Margaret A Piper, Carl Heneghan, Evelyn P Whitlock
Wichtige Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1472-6947-12-117) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

JSL, Designed and developed the framework with examples and drafted the article, and worked on final revisions; MT, designed and developed the framework with examples and drafted the article, and worked on final revisions; KAB, developed the framework with examples, revised the article for intellectual content; MAP, revised the article for intellectual content; CH, revised the article for intellectual content; EPW, Developed the initial idea for the framework, developed the framework with examples, revised the article for intellectual content. All authors read and approved the final manuscript.

Abstract

The development of genomic tests is one of the most significant technological advances in medical testing in recent decades. As these tests become increasingly available, so does the need for a pragmatic framework to evaluate the evidence base and evidence gaps in order to facilitate informed decision-making. In this article we describe such a framework that can provide a common language and benchmarks for different stakeholders of genomic testing. Each stakeholder can use this framework to specify their respective thresholds for decision-making, depending on their perspective and particular needs. This framework is applicable across a broad range of test applications and can be helpful in the application and communication of a regulatory science for genomic testing. Our framework builds upon existing work and incorporates principles familiar to researchers involved in medical testing (both diagnostic and prognostic) generally, as well as those involved in genomic testing. This framework is organized around six phases in the development of genomic tests beginning with marker identification and ending with population impact, and highlights the important knowledge gaps that need to be filled in establishing the clinical relevance of a test. Our framework focuses on the clinical appropriateness of the four main dimensions of test research questions (population/setting, intervention/index test, comparators/reference test, and outcomes) rather than prescribing a hierarchy of study designs that should be used to address each phase.
Zusatzmaterial
Additional file 1:PDF; Glossary of terms. Key terms used are defined. (PDF 52 KB)
12911_2012_592_MOESM1_ESM.pdf
Additional file 2:Search strategy and article flow. Describes the search method we used to conduct our abbreviated systematic review. The number of abstracts and articles reviewed throughout the process are also indicated. (PDF 13 KB)
12911_2012_592_MOESM2_ESM.pdf
Additional file 3:Existing frameworks used to evaluate the evidence base for genomic testing. The main frameworks used in the field of genomics are identified and described in detail. (PDF 31 KB)
12911_2012_592_MOESM3_ESM.pdf
Authors’ original file for figure 1
12911_2012_592_MOESM4_ESM.pdf
Authors’ original file for figure 2
12911_2012_592_MOESM5_ESM.pdf
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2012

BMC Medical Informatics and Decision Making 1/2012 Zur Ausgabe